Fundraising Fox
David Kirn
FounderFounder at 4D Molecular Therapeutics
San Francisco Bay Area
Founded4D Molecular Therapeutics
Find your path to David
201 people in our graph share verified history with David — schools, employers, funds. One of them is your warm intro.
Chris PeetzunlockedDavid: together at Jennerex Biotherapeutics (2012–2013)
×5David: together at Jennerex Biotherapeutics
×5David: together at 4D Molecular Therapeutics
David: together at Johnson & Johnson
Founder at 4D Molecular Therapeutics
Intro paths
→
In turn, David can intro founders to 4D Molecular Therapeutics's investors below.
4D Molecular Therapeutics's investors · 12
Amzak HealthNew York · since 2020Berkeley CatalystBerkeleyBiotechnology Value FundSan Francisco · since 2020BOLD LongevityBostonCasdin CapitalNew York · since 2020Chiesi VenturesBoston · $5M checks · since 2018Janus Henderson InvestorsNew York · since 2018Pappas CapitalDurhamPappas CapitalResearch Triangle Park · $100K – $6M checks · since 2018Pfizer Venture Investments$5M – $20M checksPfizer Venturessince 2020Viking Global InvestorsStamford · since 2020
Co-founders at 4D Molecular Therapeutics
DS
David SchafferDirector
Experience
- 4D Molecular TherapeuticsCo-Founder & CEOcurrent2013 — presentEmeryville, California
- UC BerkeleyProfessor: BioEngineering, Molecular & Cellular Biology (Adjunct)current2015 — present
- University of California, BerkeleyCo-Founder & Board Director: Life Sciences Entrepreneurship Centercurrent2020 — present
- University of California, BerkeleyLecturer & Inaugural Course co-Director: Robinson Life Sciences Business & Entrepreneurshipcurrent2019 — present
- University of California, BerkeleyAdvisory Board Member: Bakar BioEnginuity Hub2020 — 2021
- Dispatch BioSAB Membercurrent2024 — present
- IGNITE Immunotherapy - A Pfizer CompanyFounder, CEO & Executive Chair2015 — 2019
- Johnson & JohnsonJ & J Entrepreneur Innovator2013 — 2015J & J Innovation Center California
- CelgeneSVP, Global Clinical R&D, Hematology/Oncology2013 — 2014
- Jennerex BiotherapeuticsFounder & CEO2003 — 2013San Francisco, CA
- University of OxfordProfessor, Visiting (Adjunct)2002 — 2008
- Kirn Consulting: Viral Vector Gene Therapy, Oncolytics & Cancer ImmunotherapyFounder & CEO2000 — 2006San Francisco Bay Area
- Biogen IdecSenior Advisor, Clinical R&D: Viral vector gene therapy & immunotherapy for cancer2003 — 2005Greater San Diego Area
- NovartisSenior Advisor, Clinical R&D: Oncolytic virus cancer immunotherapy2000 — 2004San Francisco Bay Area
- Imperial College LondonAssociate Professor (Senior Lecturer)2000 — 2003London, United Kingdom
- UCSFAssistant Professor (Adjunct)1996 — 2000San Francisco Bay Area
- Onyx PharmaceuticalsVice President, Clinical / Translational R&D; Head, Oncolytic Virus Development1994 — 2000San Francisco Bay Area
- UCSFFellow, Medical Oncology1992 — 1994San Francisco Bay Area
- Harvard Medical SchoolChief Medical Resident1992Greater Boston Area
Skills & more
OncologyClinical ResearchClinicalBiotechnologyPharmaceuticalsTranslational ResearchTranslational MedicineCancer ResearchVirologyBiostatisticsInternal MedicineClinical Development
+12 more
Pharmaceutical IndustryLifesciencesCancerClinical TrialsHospitalsImmunologyDrug DevelopmentDrug DiscoveryStem CellsMonoclonal AntibodiesScienceAntibodiesLanguages German
From David's professional profile.
Frequently asked questions
- Who is David Kirn?
- Executive Officer, Director at 4D Molecular Therapeutics
- Where does David Kirn work?
- David Kirn is Founder of 4D Molecular Therapeutics.
- What companies did David Kirn found?
- David Kirn founded 4D Molecular Therapeutics.
- Where did David Kirn go to school?
- David Kirn studied at Harvard Medical School (Internal Medicine Residency, Brigham & Women's Hospital); University of California, San Francisco (Doctor of Medicine (MD), Medicine); University of California, Berkeley (BA, Physiology, Physical Anthropology).
Founder mafias
University of California, Berkeley, Haas School of Business mafia335
Also came through, then founded or led a company.
Harvard Medical School mafia154
Also came through, then founded or led a company.
George ChurchFounded Editas Medicine +5Sangeeta N. BhatiaDoctor of Medicine (MD)Founded Satellite Bio +4Andrey ZarurClinical ImmunologyFounded GreenLight Pandemic Response +3Howard ChangM.D.Founded Accent Therapeutics +3Michael TolentinoInstructorFounded Aviceda Therapeutics +2Andy EllnerDoctor of Medicine (M.D.)Founded Firefly Health +1
Johnson & Johnson mafia138
Also came through, then founded or led a company.
John HerrBrand Manager / Consumer MarketingFounded Arcoro +2Francisco LeonVice President & Head, Immunology Translational MedicineFounded Avalor Therapeutics +2Dirk ReynPrepulsid Team LeaderFounded Spectricity +1Serge MesserlianPresident, ActelionFounded Creyon +1Jacopo LeonardiDirector of MarketingFounded 4D Path +1Kim RodriguezDirector of SalesFounded BrainCheck +1
University of California, San Francisco mafia94
Also came through, then founded or led a company.
Geoffrey von MaltzahnMSFounded Sienna Biopharmaceuticals +5Dino Di CarloPh.D.Founded Partillion +3Luke EvninPhDFounded Mpmcapital +1Aditya KohliDoctor of Philosophy (Ph.D.)Founded Phathom Pharmaceuticals +1William GreeneMDFounded Pear Therapeutics +1Reinhard MeierPostdoctoral Research FellowshipFounded TeleClinic +1
Same school
Also attended Harvard Medical School323
Niko BonatsosFounder and Managing Partner of VerdictAnthony PhilippakisInvestor at GV (Google Ventures)Ben RobbinsInvestor at GV (Google Ventures)David ReshefInvestor at GV (Google Ventures)Krishna YeshwantInvestor at GV (Google Ventures)Morgan CheathamPartner and Head of Healthcare and Life Sciences at Breyer Capital
+ 317 more
Also attended University of California, San Francisco168
Douglas CrawfordManaging General Partner at Mission BiocapitalLuke EvninAdvisor at MPM BioImpactCharles White, Ph.D.Principal at Illumina VenturesMatt MaurerInvestor at WVV CapitalAlec NielsenFounder & CEO, Asimov & Venture Partner at Pillar VCStephan ChristgauFounding Partner at EIR Ventures
+ 162 more
Also attended University of California, Berkeley2,000
Steve WozniakCo-founder of AppleAravind SrinivasCo-founder & CEO of Perplexity AIAli GhodsiCo-founder & CEO of DatabricksAbraham BachrachCo-founder & CTO of SkydioTrevor OelschigInvestment Team at General CatalystAnthony LinHead of Intel Capital, Corporate Vice President at Intel Capital
+ 1,994 more
Also attended University of California, Berkeley, Haas School of Business966
Rishi ModiInvestor at GV (Google Ventures)Yibo NianInvestment Director at Intel CapitalZhenyu TangInvestment Director at Intel CapitalDennisDirector of Trading at Pantera CapitalAnna ChenInvestor at Madrona Venture GroupJohnny HooperAssociate at March Capital Partners
+ 960 more
Shared employers
Also worked at Dispatch Bio3
Also worked at Johnson & Johnson356
Teresa ChanChief Financial Officer at Felicis VenturesKarthik ArdhanareeswaranInvestor at GV (Google Ventures)KobeFinance Director at Hummingbird VenturesMickelFinance & Risk Management at Hummingbird VenturesHal PazInvestor at Khosla VenturesNiall O'DonnellManaging Director at RiverVest Venture Partners
+ 350 more
Also worked at Jennerex Biotherapeutics6
Chris PeetzEntrepreneur-in-Residence at Frazier Life SciencesLaurent FischerDirector at atai Life SciencesSamantha Miller 🌱Founder at Cadence Health Liberate the PillTheresa JankeExecutive Officer at 4D Molecular TherapeuticsTerry HermistonFounder & CEO at Coagulant Therapeutics Venture CapitalKen NewportExecutive Officer at Virica
Also worked at Novartis325
Rebecca JamesInvestor at Index VenturesScott BillerInvestor at GV (Google Ventures)Freya Svedberg-KeatingInvestor at MedicxiAndrea AmadorCompliance Manager at Inveready Technology Investment GroupAbbie CelnikerInvestor at Third Rock VenturesJesper GromadaInvestor at Third Rock Ventures
+ 319 more